Brief: ObsEva SA Has Been Selected For Addition To Nasdaq Biotechnology Index
20/12/2021 12:20
Dec 20 (Reuters) - Obseva SA OBSN.S :
* OBSEVA SA - HAS BEEN SELECTED FOR ADDITION TO NASDAQ
BIOTECHNOLOGY INDEX
Source text for Eikon: ID:nGNX79njjs
Further company coverage: OBSN.S
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Obseva SA
See all newsBrief: Obseva Announces Wind-Down Of Operations And Likely Not Going To Be Able To Satisfy Requirements For Maintaining Its Listing
Brief: Obseva Applies For Moratorium To Facilitate Pivotal Deals
Brief: Obseva SA Says Xoma Will Receive Full Worldwide Rights On Ebopiprant Following Termination Of License Agreement With Organon
Brief: Obseva Appoints Fabien De Ladonchamps As Chief Executive Officer Effective May 1, 2023
Brief: Obseva Announces Change Of Central Securities Depositary